DeCarolis DD - Search Results

1

Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection.

Shaughnessy MK, Amundson WH, Kuskowski MA, DeCarolis DD, Johnson JR, Drekonja DM. Shaughnessy MK, et al. Among authors: decarolis dd. Infect Control Hosp Epidemiol. 2013 Feb;34(2):109-16. doi: 10.1086/669089. Epub 2012 Dec 19. Infect Control Hosp Epidemiol. 2013. PMID: 23295554

2

Comparison of plasma concentrations for two amiodarone products.

Sauro SC, DeCarolis DD, Pierpont GL, Gornick CC. Sauro SC, et al. Among authors: decarolis dd. Ann Pharmacother. 2002 Nov;36(11):1682-5. doi: 10.1345/aph.1A403. Ann Pharmacother. 2002. PMID: 12398559

3

Information resources used in antimicrobial prescribing.

Sellman JS, Decarolis D, Schullo-Feulner A, Nelson DB, Filice GA. Sellman JS, et al. J Am Med Inform Assoc. 2004 Jul-Aug;11(4):281-4. doi: 10.1197/jamia.M1493. Epub 2004 Apr 2. J Am Med Inform Assoc. 2004. PMID: 15064289 Free PMC article.

4

Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.

DeCarolis DD, Rice KL, Ho L, Willenbring ML, Cassaro S. DeCarolis DD, et al. Pharmacotherapy. 2007 Apr;27(4):510-8. doi: 10.1592/phco.27.4.510. Pharmacotherapy. 2007. PMID: 17381377

5

Treatment of non-life-threatening methicillin-resistant Staphylococcus aureus infections with alternative antimicrobial agents: a 2-year retrospective review.

Drekonja DM, Traynor LM, DeCarolis DD, Crossley KB, Johnson JR. Drekonja DM, et al. Among authors: decarolis dd. Diagn Microbiol Infect Dis. 2009 Feb;63(2):201-7. doi: 10.1016/j.diagmicrobio.2008.10.001. Epub 2008 Nov 21. Diagn Microbiol Infect Dis. 2009. PMID: 19026510

6

Antimicrobial use and risk for recurrent Clostridium difficile infection.

Drekonja DM, Amundson WH, Decarolis DD, Kuskowski MA, Lederle FA, Johnson JR. Drekonja DM, et al. Among authors: decarolis dd. Am J Med. 2011 Nov;124(11):1081.e1-7. doi: 10.1016/j.amjmed.2011.05.032. Epub 2011 Sep 22. Am J Med. 2011. PMID: 21944159

7

Enoxaparin outcomes in patients with moderate renal impairment.

DeCarolis DD, Thorson JG, Clairmont MA, Leuthner AM, Rector TS, Johnson GJ. DeCarolis DD, et al. Arch Intern Med. 2012 Dec 10;172(22):1713-8. doi: 10.1001/2013.jamainternmed.369. Arch Intern Med. 2012. PMID: 23128835

8

Evaluation of a Potential Interaction Between New Regimens to Treat Hepatitis C and Warfarin.

DeCarolis DD, Westanmo AD, Chen YC, Boese AL, Walquist MA, Rector TS. DeCarolis DD, et al. Ann Pharmacother. 2016 Nov;50(11):909-917. doi: 10.1177/1060028016660325. Epub 2016 Jul 28. Ann Pharmacother. 2016. PMID: 27465881

9

Decreased warfarin sensitivity among patients treated with elbasvir and grazoprevir for hepatitis C infection.

DeCarolis DD, Chen YC, Westanmo AD, Conley C, Gravely AA, Khan FB. DeCarolis DD, et al. Am J Health Syst Pharm. 2019 Sep 1;76(17):1273-1280. doi: 10.1093/ajhp/zxz127. Am J Health Syst Pharm. 2019. PMID: 31418789

10

Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy?

DeCarolis DD, Thorson JG, Marraffa RA, Clairmont MA, Kuskowski MA. DeCarolis DD, et al. Ther Drug Monit. 2014 Oct;36(5):632-9. doi: 10.1097/FTD.0000000000000065. Ther Drug Monit. 2014. PMID: 25222855

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results